Aptar Pharma is nearing completion on its expansion at its Congers, NY, state-of-the-art manufacturing site where it will offer injectable elastomeric component manufacturing for the first time in the U.S. Final construction is planned by the end of the first quarter of 2017. Shipping validation batches to customers will commence in the second quarter of next year. The expansion is part of a stepped program to increase Aptar Pharma’s footprint in the U.S., according to Bas Van Buijtenen, pres...